Transplantation, AutologousPeripheral Blood Stem Cell TransplantationHematopoietic Stem Cell TransplantationHematopoietic Stem Cell MobilizationTransplantation ConditioningMelphalanTransplantation, HomologousCombined Modality TherapyAntigens, CD34Bone Marrow TransplantationGranulocyte Colony-Stimulating FactorLeukapheresisMultiple MyelomaBlood Component RemovalCyclophosphamideAntineoplastic Combined Chemotherapy ProtocolsLymphoma, Non-HodgkinHematologic NeoplasmsTreatment OutcomeGraft SurvivalStem Cell TransplantationLiver TransplantationBusulfanHematopoietic Stem CellsEtoposideMyeloablative AgonistsCarmustineRemission InductionSalvage TherapyThiotepaRecurrenceBlood Transfusion, AutologousAntineoplastic Agents, AlkylatingKidney TransplantationHodgkin DiseaseCytarabineBone Marrow PurgingVincristineCytophagocytosisHematopoiesisGraft vs Host DiseaseIfosfamideDisease-Free SurvivalRetrospective StudiesTime FactorsSurvival RateWhole-Body IrradiationBlood Cell CountNeoplasmsSurvival AnalysisStem CellsHeart TransplantationAmyloidosisTissue DonorsDoxorubicinLung TransplantationLeukocytes, MononuclearCell TransplantationFollow-Up StudiesPrednisoneDexamethasonePlatelet CountImmunosuppressive AgentsTransplantation ChimeraCord Blood Stem Cell TransplantationRecombinant ProteinsT-LymphocytesLymphoma, T-CellFeasibility StudiesLeukemia, Myeloid, AcuteCarboplatinLymphomaCell SeparationAntineoplastic AgentsProspective StudiesCells, CulturedOrgan TransplantationTransplantation ImmunologyInfectionTransplantation, IsogeneicFlow CytometryGraft RejectionImmunomagnetic SeparationBlood CellsBone MarrowLymphocytesImmunophenotypingLymphocyte ActivationIslets of Langerhans TransplantationPrognosisHistocompatibility TestingPancreas TransplantationTransplantationLeukemiaHistocompatibilityCytomegalovirus InfectionsFatal OutcomeBone Marrow CellsBreast NeoplasmsImmunosuppression